Results 161 to 170 of about 48,095 (189)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure

ESC Heart Failure, EarlyView.
NT‐proBNP plasma concentrations were measured in participants of two NZ HF cohorts and were significantly lower in Pacific peoples and Māori compared with NZ Europeans. After accounting for age, sex, BMI, eGFR, LVEF and presence of AF, NT‐proBNP plasma concentrations remained significantly lower for Pacific peoples, but not for Māori.
Andree G. Pearson, John F. Pearson, Lynley K. Lewis, Allamanda Fa'atoese, Katrina K. Poppe, Chris Pemberton, Gerry Devlin, Mayanna Lund, A. Mark Richards, Richard Troughton, Robert N. Doughty   +10 more
wiley   +1 more source

A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi. [PDF]

Open Life Sci
Murshed M, Al-Tamimi J, Ibrahim KE, Al-Quraishy S.   +3 more
europepmc   +1 more source

Effect of cinnamon oil (<i>Cinnamomum burmannii</i>) on the histological kidney of male diabetic rats (<i>Rattus norvegicus</i>). [PDF]

Open Vet J
Budiastuti B, Noviana Thesia NL, Plumeriastuti H, Effendi MH, Ugbo EN, Khairullah AR, Moses IB, Priscilia Riwu KH, Ahmad RZ, Yanestria SM, Wasito W, Pratama BP, Awwanah M, Prasetyo A.   +13 more
europepmc   +1 more source

Real‐world use of guideline‐directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Failure, EarlyView.
Our study examined the real‐world implementation of guideline‐directed medical therapy (GDMT) and its association with mortality and hospitalization in 46 816 patients with heart failure with reduced ejection fraction (HFrEF) from the Danish Heart Failure Registry (2008–2022).
Inge Schjødt, Jan B. Valentin, Søren P. Johnsen, Rikke E. Mols, Kenneth Egstrup, Brian B. Løgstrup   +5 more
wiley   +1 more source

Late Presentation of Galloway-Mowat Syndrome (GAMOS) Associated With Membranous Nephropathy: A Case Report. [PDF]

Cureus
Yeboah EK, Salvatore S, Sasidharan S, Khan S, Saggi S.   +4 more
europepmc   +1 more source

METAB‐HTX: prospective, longitudinal cohort study evaluating cardiac and systemic metabolism after heart transplantation

ESC Heart Failure, EarlyView.
The METAB‐HTX trial is a prospective cohort study, evaluating cardiac and systemic metabolism among heart transplant recipients. Myocardial function, energetic and metabolism, allograft vasculopathy, allograft rejection, glucometabolism, lipometabolism, liver‐ and kidney function, leucocyte signatures and thromboinflammation will be evaluated ...
Amin Polzin, Daniel Scheiber, Fabian Voss, Jean Haurand, Elric Zweck, Daniel Oehler, Oliver Maier, Mareike Cramer, Maximilian Spieker, Constanze Moos, Ursala Tokhi, David Naguib, Philipp Mourikis, Marcel Benkhoff, Robert Wagner, Michael Roden, Heinz‐Peter Schultheiss, Sascha Dietrich, Hug Aubin, Udo Boeken, Artur Lichtenberg, Malte Kelm   +21 more
wiley   +1 more source

Increased HA/CD44/TGFβ signaling implicates in renal fibrosis of a Col4a5 mutant Alport mice. [PDF]

Mol Med
Bao Y, Wu W, Lin J, Yang Y, Lin S, Su J, Qin Y, Wang B, Duan S.   +8 more
europepmc   +1 more source

A two‐phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) with preserved ejection fraction (HFpEF) poses significant diagnostic challenges due to its complex aetiology and overlapping symptoms with other HF types. The heterogeneity of HFpEF, compounded by frequent comorbidities, complicates diagnosis. This study aimed to enhance HFpEF prediction through a two‐phase approach: a
Izabella Uchmanowicz, Magdalena Lisiak, Piotr Ponikowski, Ewa A. Jankowska, Andrzej Mysiak, Marta Wleklik   +5 more
wiley   +1 more source

Clinical course and outcome of adult patients with primary focal segmental glomerulosclerosis with kidney function loss on presentation. [PDF]

World J Nephrol
Jafry NH, Sarwar S, Waqar T, Mubarak M.
europepmc   +1 more source

Association of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study

European Journal of Heart Failure, EarlyView.
Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.
Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar   +9 more
wiley   +1 more source